[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100498861":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":25,"responsibleParty":39,"collaborators":7,"id":42,"slug":7,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":55,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":7,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Samsung Medical Center","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"RADIATION","Hypofractionated radiation therapy","Both 3-week and 1-week hypofractioanted radiation therapy are allowed. (simultaneous or sequential tumor bed boost is allowed.) A 3-week regimen includes 42.4 Gy in 16 fractions. A 1-week regimen includes 26 Gy in 5 fractions or 28.5 Gy in 3 fractions, 30 Gy in 5 fractions.",[14],{"name":15,"affiliation":5,"role":16},"Haeyoung Kim, MD, PhD","PRINCIPAL_INVESTIGATOR",[18,22],{"name":15,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","82-2-3410-2612","haeyoung0131.kim@samsung.com",{"name":23,"role":19,"phone":20,"phoneExt":7,"email":24},"Nalee Kim, MD, PhD","rodr.naleekim@gmail.com",[26],{"facility":5,"status":27,"city":28,"state":7,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Seoul","06351","South Korea",{"type":32,"coordinates":33},"Point",[34,35],126.9784,37.566,{"lat":35,"lon":34},[38],{"name":15,"role":19,"phone":20,"phoneExt":7,"email":21},{"type":16,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Haeyoung Kim","Associate professor","100498861",false,"NCT05775757","SMC Radiation Oncology Breast Cancer Cohort Study","Registry for Analysis of Impact of Radiation Dose to Skin on Cosmetic Outcome and Patient-reported Outcomes in Patients With Breast Cancer Treated With Radiation Therapy","RASCO","Inclusion Criteria:\n\n* Breast cancer treated with curative surgery\n\nExclusion Criteria:\n\n* History of thoracic radiation therapy","FEMALE","18 Years","85 Years",{"count":53,"type":54},500,"ESTIMATED","2 Years","OBSERVATIONAL","The goal of this observational study is to learn about toxicities and cosmetic outcomes in breast cancer patients treated with hypofractionated radiotherapy.\n\nThe main question it aims to answer are:\n\n* Changes in breast skin\n* Factors related to breast skin changes\n* Patient-reported outcomes\n* Cosmetic outcomes\n\nParticipants will be assessed by multi-dimensional methods before and after radiotherapy:\n\n* Photographs\n* Fibrometer\n* Questionnaires (BREAST-Q)\n* CTCAE version 4.03 evaluated by treating physicians",[59],"Radiotherapy Side Effect","2025-06-27",{"date":62,"type":63},"2025-06-29","ACTUAL",{"date":65,"type":63},"2021-01-01",{"date":67,"type":54},"2030-12-31",{"name":5,"class":6},1]